Hologic (LTS:0J5Q) Institutional Ownership : 71.53% (As of May. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hologic Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hologic's institutional ownership is 71.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hologic's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hologic's Float Percentage Of Total Shares Outstanding is 66.65%.

Hologic Institutional Ownership Historical Data

The historical data trend for Hologic's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic Institutional Ownership Chart

Hologic Historical Data

The historical data trend for Hologic can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	75.94	74.80	74.57	70.18	69.62	71.12	69.57	69.97	71.71	71.53

Hologic Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Hologic (LTS:0J5Q) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (LTS:0J5Q) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

HOLX:USA HOLX:Mexico HO1:Germany HOLX:Austria

Address

250 Campus Drive, Marlborough, MA, USA, 01752

Website

http://www.hologic.com

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (LTS:0J5Q) Headlines

No Headlines